PL409015A1 - N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine - Google Patents
N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamineInfo
- Publication number
- PL409015A1 PL409015A1 PL409015A PL40901514A PL409015A1 PL 409015 A1 PL409015 A1 PL 409015A1 PL 409015 A PL409015 A PL 409015A PL 40901514 A PL40901514 A PL 40901514A PL 409015 A1 PL409015 A1 PL 409015A1
- Authority
- PL
- Poland
- Prior art keywords
- polyallylamine
- sulfonic
- derivative
- hmpv
- pharmaceutical composition
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Przedmiotem wynalazku jest N-sulfonowa pochodna polialliloaminy (NSPAH) o wzorze 1, w którym R oznacza -SO3 albo -H, a n oznacza liczbę całkowitą od 150 do 15000, zastosowanie N-sulfonowej pochodnej polialliloaminy jako leku, zwłaszcza do profilaktyki i leczenia infekcji dróg oddechowych, wywołanych ludzkim metapneumowirusem (hMPV) oraz kompozycja farmaceutyczna zawierająca N-sulfonową pochodną polialliloaminy i jej zastosowanie.The subject of the invention is a N-sulfone polyallylamine derivative (NSPAH) of the formula 1, wherein R is -SO3 or -H and n is an integer from 150 to 15000, the use of the N-sulfone polyallylamine derivative as a medicament, especially for the prophylaxis and treatment of respiratory infections respiratory diseases caused by human metapneumovirus (hMPV) and a pharmaceutical composition comprising an N-sulfone polyallylamine derivative and its use.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL409015A PL228171B1 (en) | 2014-07-29 | 2014-07-29 | N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine |
EP15763979.0A EP3174908B1 (en) | 2014-07-29 | 2015-07-29 | Anionically modified n-sulfonic polyallylamine derivative, pharmaceutical composition comprising the n-sulfonic polyallylamine derivative as the active substance and use of the n-sulfonic polyallylamine derivative for the production of a medicine |
PCT/IB2015/055727 WO2016016820A2 (en) | 2014-07-29 | 2015-07-29 | Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hmpv), human rhinoviruses (hrv), and infection by influenza virus type a (iav) and pharmaceutical composition comprising the anionically modified polyallylamine derivative |
CA2955406A CA2955406A1 (en) | 2014-07-29 | 2015-07-29 | Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hmpv), human rhinoviruses (hrv), and infection by influenza virus type a (iav) and pharmaceutical composition comprising the... |
US15/329,324 US20170216347A1 (en) | 2014-07-29 | 2015-07-29 | Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hmpv), human rhinoviruses (hrv), and infection by influenza virus type a (iav) and pharmaceutical composition comprising the anionically modified polyallylamine derivative |
US15/792,962 US9925215B1 (en) | 2014-07-29 | 2017-10-25 | Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hMPV), human rhinoviruses (HRV), and infection by influenza virus type A (IAV) and pharmaceutical composition comprising the anionically modified polyallylamine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL409015A PL228171B1 (en) | 2014-07-29 | 2014-07-29 | N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine |
Publications (2)
Publication Number | Publication Date |
---|---|
PL409015A1 true PL409015A1 (en) | 2016-02-01 |
PL228171B1 PL228171B1 (en) | 2018-02-28 |
Family
ID=55178445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL409015A PL228171B1 (en) | 2014-07-29 | 2014-07-29 | N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL228171B1 (en) |
-
2014
- 2014-07-29 PL PL409015A patent/PL228171B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL228171B1 (en) | 2018-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019550050A1 (en) | Isoxazole analogs as fxr agonists and methods of use thereof | |
MX2022010520A (en) | Peptide macrocycles against acinetobacter baumannii. | |
GEP20217248B (en) | 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh | |
MX2016013529A (en) | Amide derivatives and pharmaceutically acceptable salts thereof, preparation method therefor and medicinal application thereof. | |
NZ733174A (en) | Quinazoline derivatives used to treat hiv | |
EA202090486A3 (en) | COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCLE ATROPHY | |
NZ751197A (en) | Compounds and methods of treating infections | |
EA201891063A1 (en) | DERIVATIVES OF DIHYDROIMIDAZOPIRAZINONE APPLICABLE IN THE TREATMENT OF CANCER | |
BR112015003188A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, COMPOUND USE, AND METHOD FOR TREATMENT OF A RORGAMMAT-MEDIATED DISEASE OR CONDITION IN A PATIENT | |
CR20180253A (en) | THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF HUMAN UNMUNODEFICIENCY VIRUS | |
PH12016502353A1 (en) | Pharmaceutical composition | |
PH12016502352A1 (en) | Pharmaceutical composition | |
NZ607580A (en) | N-heteroaryl compounds | |
EA201590364A1 (en) | APPLICATION OF AIRWAY PERSON, HIS SALTS AND CRYSTALLINE FORMS AND COMPOSITIONS, ITS CONTAINING, FOR THE TREATMENT OF ZUD | |
PH12016502039A1 (en) | Potent and selective inhibitors of hepatitis c virus | |
EA201692111A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES | |
EA201792264A1 (en) | METHODS OF TREATING INFLAMMATORY DISEASES | |
MX2019007213A (en) | Condensed ring group azacyclobutyl triazole derivative, preparation method therefor and use thereof in medicine. | |
MX2018002177A (en) | Novel catechol derivative and pharmaceutical composition comprising same. | |
BR112016029619A8 (en) | FLUOROQUINOLONE CLASS COMPOUNDS, PHARMACEUTICAL COMPOSITION AND DRUG COMPRISING SUCH COMPOUNDS AND USES OF SUCH COMPOUNDS | |
PH12016502480A1 (en) | Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases | |
PL409015A1 (en) | N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine | |
EA201792265A1 (en) | METHODS OF TREATING CARDIOVASCULAR DISEASES | |
WO2016016820A3 (en) | Anionically modified n-sulfonic polyallylamine derivative, pharmaceutical composition comprising the n-sulfonic polyallylamine derivative as the active substance and use of said derivate for the production of a medicine | |
EA201692532A1 (en) | ANTIMICROBIAL COMPOSITIONS WITH PIPE SUBSTANCES |